HPWM
OGN icon

High Point Wealth Management’s Organon & Co OGN Stock Holding History

High Point Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$36 – 265
2025
Q4 		$36 Buy
+5
New +$40 ﹤0.01% 247

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

High Point Wealth Management's OGN Position: Q1 2026 in Review

High Point Wealth Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 5 shares — an estimated $36 sold.

High Point Wealth Management first reported a position in OGN in Q4 2025 and held it in 1 quarter. The position peaked at $36 in Q4 2025. 606 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • High Point Wealth Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • High Point Wealth Management sold 5 Organon & Co shares in Q1 2026, an estimated $36.
  • High Point Wealth Management first reported a position in Organon & Co in Q4 2025 and held it in 1 quarter.
  • High Point Wealth Management's Organon & Co position peaked at $36 in Q4 2025.
  • 606 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on High Point Wealth Management's 13F filing for Q1 2026, filed 8 Apr 2026.